You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

~ Buy the SUNOSI (solriamfetol hydrochloride) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR SUNOSI

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for sunosi

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04602936 ↗	Solriamfetol in Binge Eating Disorder	Not yet recruiting	Jazz Pharmaceuticals	Phase 4	2020-11-15	The goal of this project is to evaluate the efficacy and tolerability of the novel dopamine and norepinephrine reuptake inhibitor (DNRI) solriamfetol in the treatment of binge eating disorder (BED).
NCT04602936 ↗	Solriamfetol in Binge Eating Disorder	Not yet recruiting	Lindner Center of HOPE	Phase 4	2020-11-15	The goal of this project is to evaluate the efficacy and tolerability of the novel dopamine and norepinephrine reuptake inhibitor (DNRI) solriamfetol in the treatment of binge eating disorder (BED).
NCT04622293 ↗	A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	Not yet recruiting	Rochester Center for Behavioral Medicine	Phase 4	2021-04-01	This study is an 8-week single center, randomized, double-blind, placebo-controlled, flexible titration trial evaluating the efficacy of solriamfetol in the treatment of fatigue symptoms in adult patients with chronic fatigue syndrome. Subjects will be randomized to a solriamfetol group or placebo group. The investigators will utilize an intent to treat model and impute data. The overall goal of this study is to determine the efficacy and effectiveness of solriamfetol for treating chronic fatigue syndrome.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for sunosi

Condition Name

Chart
Table

Condition Name for sunosi
Intervention	Trials
Excessive Sleepiness	2
Myalgic Encephalomyelitis	1
Narcolepsy	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for sunosi
Intervention	Trials
Fatigue	2
Sleepiness	2
Disorders of Excessive Somnolence	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for sunosi

Trials by Country

Map
Table

Trials by Country for sunosi
Location	Trials
United States	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for sunosi
Location	Trials
Maryland	1
North Carolina	1
Massachusetts	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for sunosi

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for sunosi
Clinical Trial Phase	Trials
Phase 4	4
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for sunosi
Clinical Trial Phase	Trials
Recruiting	3
Not yet recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for sunosi

Sponsor Name

Chart
Table

Sponsor Name for sunosi
Sponsor	Trials
Jazz Pharmaceuticals	3
Axsome Therapeutics, Inc.	1
National Multiple Sclerosis Society	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for sunosi
Sponsor	Trials
Other	5
Industry	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.